Physical training and low doses of heparin calcium in patients suffering from chronic obliterating arteriopathy of the lower limbs with claudicatio intermittens;TRAINING FISICO ED EPARINA CALCICA A BASSE DOSI IN PAZIENTI AFFETTI DA ARTERIOPATIA OBLITERANTE CRONICA DEGLI ARTI INFERIORI CON CLAUDICATIO INTERMITTENS

Minerva Cardioangiologica

Volumn 44, Issue 4, 1996, Pages 179-185

  Cina, G ^{a,b,c,d,e,f,g}   Vernich, M ^a   Campisi, C ^a   Cascone, C ^a   Ofria, F ^a   Leopardi, N ^a   Maniscalco, G ^a   Moricca, N ^a   Ceccarelli, V ^a   Paolicelli, D ^a   Carbone, D ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

^c CNR   (Italy)

^d SAN FILIPPO NERI HOSPITAL   (Italy)

^e Ospedale Cristo Re   (Italy)

^f SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^g Villa Betania Hospital   (Italy)

Author keywords

heparin calcium; intermittent claudication; physical training

Indexed keywords

HEPARIN CALCIUM;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EXERCISE; FEMALE; GAIT; HEMATURIA; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RANDOMIZED CONTROLLED TRIAL; RASH; STOMACH PAIN; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALYSIS OF VARIANCE; ARTERIAL OCCLUSIVE DISEASES; CHRONIC DISEASE; EXERCISE THERAPY; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC;

EID: 8944236545     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Spartera C Arteriopatie periferiche e ischemia critica. Stampa Medica 1990:37-44
2. Hughson WG, Mann JI, Garrod A. Intermittent claudication: prevalence and risk factors. Br Med J 1978,1:1379-81
3. Schoop W Mechanism, of beneficial acton of daily walking training of patients with intermittent claudication. Scand J Clin Lab Invest 1973;31(Suppl128).197-1993.
4. Zetterquist S. The effect of active training on the nutritive blood flow in exercising ischemic legs. Scand J Clin Lav Invest 1970;25:101-11
5. Christe M, Delley A, Marbot GA et al. Fibrinogen, factor VIII related antigen, anti thrombin III and alpha 2 antiplasmin in peripheral arterial disease. Thromb Haemost 1984;52:204-42.
6. De Felice M, Gallo P, Masotti G. Current therapy of peripheral obstrutive arterial disease: non surgical approach. Angiology 1990,41:1-11.
7. Cacciaguerra G, Botto G, Monaco G et al. Effetti dell'eparina calcica sulla performance deambulatoria di arteriopatici periferici allo stadio IIb di Leriche e Fontaine. Minerva Angiol 1991;6:71-4
8. Andreozzi GM, Signorelli SS, Cacciaguerra G et al. Three-month therapy with calcium-heparin in comparison with ticlopidine in patients with peripheral arterial occlusive diseases at Leriche-Fontaine IIb class. Angiology 1993;4:307-13.
9. Montesi T. Efficacia di eparina calcica ed ASA nella terapia a lungo termine di soggetti affetti da arteriopatia obliterante degli arti inferiori. Minerva Angiol 1991,16(Suppl1) 148-9.
10. Allegra A, Pollari G, Carioti B et al. Thrombin and platelet inhibition with low-dose calcium-heparin in comparison with ASA in patients with peripheral arterial occlusive disease at Leriche-Fontaine IIb class. Int J Clin Pharmacol Ther 1994; 32:646-51.